The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Complement in the brain
Open accessAbstract
The brain is considered to be an immune privileged site, because the blood-brain barrier limits entry of blood borne cells and proteins into the central nervous system (CNS). As a result, the detection and clearance of invading microorganisms and senescent cells as well as surplus neurotransmitters, aged and glycated proteins, in order to maintain a healthy environment for neuronal and glial cells, is largely confined to the innate immune system. In recent years it has become clear that many factors of innate immunity are expressed throughout the brain. Neuronal and glial cells express Toll like receptors as well as complement receptors, and virtually all complement components can be locally produced in the brain, often in response to injury or developmental cues. However, as inflammatory reactions could interfere with proper functioning of the brain, tight and fine tuned regulatory mechanisms are warranted. In age related diseases, such as Alzheimer’s disease (AD), accumulating amyloid proteins elicit complement activation and a local, chronic inflammatory response that leads to attraction and activation of glial cells that, under such activation conditions, can produce neurotoxic substances, including pro-inflammatory cytokines and oxygen radicals. This process may be exacerbated by a disturbed balance between complement activators and complement regulatory proteins such as occurs in AD, as the local synthesis of these proteins is differentially regulated by pro-inflammatory cytokines. Much knowledge about the role of complement in neurodegenerative diseases has been derived from animal studies with transgenic overexpressing or knockout mice for specific complement factors or receptors. These studies have provided insight into the potential therapeutic use of complement regulators and complement receptor antagonists in chronic neurodegenerative diseases as well as in acute conditions, such as stroke. Interestingly, recent animal studies have also indicated that complement activation products are involved in brain development and synapse formation. Not only are these findings important for the understanding of how brain development and neural network formation is organized, it may also give insights into the role of complement in processes of neurodegeneration and neuroprotection in the injured or aged and diseased adult central nervous system, and thus aid in identifying novel and specific targets for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 2×
“Complement proteins were found to promote proliferation and regeneration in various tissues (reviewed in (Ricklin et al., 2010)) and may exert similar functions in the CNS, as neuronal stem cells differentiate and migrate in response to C. C3a-C3aR interactions were found to be a positive regulator…”
BackgroundHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
NeuN, a neuronal specific nuclear protein in vertebratesxs
Mullen, R. J., Buck, C. R., & Smith, A. M. (1992) · Development · doi:10.1242/dev.116.1.201 · Cited by 2,351
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Adult neurogenesis and functional plasticity in neuronal circuits
Lledo, P.-M., Alonso, M., & Grubb, M. S. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1867 · Cited by 1,366
Dong, Y., & Benveniste, E. N. (2001) · Glia · doi:10.1002/glia.1107 · Cited by 1,293
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
Unbiased stereological estimation of the number of neurons in the human hippocampus
West, M. J., & Gundersen, H. J. G. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902960102 · Cited by 1,153
The complement system in regulation of adaptive immunity
Carroll, M. C. (2004) · Nature Immunology · doi:10.1038/ni1113 · Cited by 1,035
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730 · cited 2×
“Since there are two C5aR (CD88 and C5L2) and there are suggestions that these receptors may “cooperate” with other receptors (reviewed in (Klos et al., 2009), it is possible that a diverse, but precise, set of responses to a changing environment could be orchestrated depending on the repertoire of…”
BackgroundSelf-citationImmune activation in brain aging and neurodegeneration: too much or too little?
Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679
Ford, A. L., Goodsall, A. L., Hickey, W. F., & Sedgwick, J. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4309 · Cited by 631
CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens
Helmy, K. Y., Katschke, K. J., Gorgani, N. N., Kljavin, N. M., Elliott, J. M., Diehl, L., Scales, S. J., Ghilardi, N., & van Lookeren Campagne, M. (2006) · Cell · doi:10.1016/j.cell.2005.12.039 · Cited by 628
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565
Immune proteins in brain development and synaptic plasticity
Boulanger, L. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.001 · Cited by 555
(1997) · doi:10.1073/pnas.94.4.1550 · Cited by 535
Wessels, M. R., Butko, P., Ma, M., Warren, H. B., Lage, A. L., & Carroll, M. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11490 · Cited by 503
Irizarry, M. C., Soriano, F., McNamara, M., Page, K. J., Schenk, D., Games, D., & Hyman, B. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-18-07053.1997 · Cited by 497
Role of toll-like receptor signalling in A uptake and clearance
Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006) · Brain · doi:10.1093/brain/awl249 · Cited by 493
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
Koenigsknecht-Talboo, J., & Landreth, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1808-05.2005 · Cited by 477
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454 · cited 6×
“Role of toll- like receptor signalling in Abeta uptake and clearance.”
BackgroundInfluentialImmunopathology of secondary‐progressive multiple sclerosis
Prineas, J. W., Kwon, E. E., Cho, E., Sharer, L. R., Barnett, M. H., Oleszak, E. L., Hoffman, B., & Morgan, B. P. (2001) · Annals of Neurology · doi:10.1002/ana.1255 · Cited by 453
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446
Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APP Sw,Ind ) mice
Jin, K., Galvan, V., Xie, L., Mao, X. O., Gorostiza, O. F., Bredesen, D. E., & Greenberg, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403678101 · Cited by 436
Brain microglia constitutively express β-2 integrins
Akiyama, H., & McGeer, P. L. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90055-r · Cited by 430
Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination
Storch, M. K., Piddlesden, S., Haltia, M., Iivanainen, M., Morgan, P., & Lassmann, H. (1998) · Annals of Neurology · doi:10.1002/ana.410430409 · Cited by 422
The role of microglia in central nervous system immunity and glioma immunology
Yang, I., Han, S. J., Kaur, G., Crane, C., & Parsa, A. T. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.05.006 · Cited by 410 · cited 1×
“…immune effector cells and are able to produce cytokines and chemokines as well as to phagocytose up targets upon stimulation (Dong and Benveniste, 2001;Nielsen et al., 2010;Familian et al., 2007;Nielsen et al., 2009;Fraser et al., 2010;Bohlson et al., 2007;Yang et al., 2010;Watabe et al., 1989).”
BackgroundActivation of the classical complement pathway in brain tissue of Alzheimer patients
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383
Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro
Lue, L., Rydel, R., Brigham, E. F., Yang, L., Hampel, H., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 382
Regulation of Toll-like receptor–mediated inflammatory response by complement in vivo
Zhang, X., Kimura, Y., Fang, C., Zhou, L., Sfyroera, G., Lambris, J. D., Wetsel, R. A., Miwa, T., & Song, W.-C. (2007) · Blood · doi:10.1182/blood-2006-12-063636 · Cited by 373
Complement activation and inhibition: a delicate balance
Sjöberg, A. P., Trouw, L. A., & Blom, A. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.11.003 · Cited by 364
Enhanced synaptic connectivity and epilepsy in C1q knockout mice
Chu, Y., Jin, X., Parada, I., Pesic, A., Stevens, B., Barres, B., & Prince, D. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913449107 · Cited by 364
Homogeneity of active demyelinating lesions in established multiple sclerosis
Breij, E. C. W., Brink, B. P., Veerhuis, R., van den Berg, C., Vloet, R., Yan, R., Dijkstra, C. D., van der Valk, P., & Bö, L. (2008) · Annals of Neurology · doi:10.1002/ana.21311 · Cited by 353
Self-citationAbsence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease
Fonseca, M. I., Zhou, J., Botto, M., & Tenner, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0901-04.2004 · Cited by 345
Self-citationJiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330 · cited 1×
“…2001;Snyder et al., 1994;Velazquez et al., 1997), validated the activation of C by beta sheet amyloid fibrils and identified candidate amino acids on both the amyloid and the C1q molecule that are involved in the interaction (Velazquez et al., 1997;Jiang et al., 1994;Tacnet-Delorme et al., 2001).”
BackgroundSelf-citationFibrillar Amyloid-β Peptides Activate Microglia via TLR2: Implications for Alzheimer’s Disease
Jana, M., Palencia, C. A., & Pahan, K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7254 · Cited by 330
Up-Regulated Production and Activation of the Complement System in Alzheimer's Disease Brain
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65340-0 · Cited by 327
Maier, M., Peng, Y., Jiang, L., Seabrook, T. J., Carroll, M. C., & Lemere, C. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0829-08.2008 · Cited by 323
CR3: a general purpose adhesion-recognition receptor essential for innate immunity
Ehlers, M. R. W. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00299-9 · Cited by 323
Role of complement in neurodegeneration and neuroinflammation
BONIFATI, D., & KISHORE, U. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.03.007 · Cited by 313
Broadwell, R. D., & Sofroniew, M. V. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1059 · Cited by 309
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease
Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., Olschowka, J. A., Fonseca, M. I., O’Banion, M. K., Tenner, A. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64085-0 · Cited by 303
Self-citationComplement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemuller, J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
Jin, J.-J., Kim, H.-D., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-23 · Cited by 275
Fonseca, M. I., Ager, R. R., Chu, S.-H., Yazan, O., Sanderson, S. D., LaFerla, F. M., Taylor, S. M., Woodruff, T. M., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901005 · Cited by 268
Self-citationWebster, S., Lue, L.-F., Brachova, L., Tenner, A. J., McGeer, P. L., Terai, K., Walker, D. G., Bradt, B., Cooper, N. R., & Rogers, J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00042-0 · Cited by 258
Self-citationComplement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide
Bradt, B. M., Kolb, W. P., & Cooper, N. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.431 · Cited by 255
Complement and viral pathogenesis
Stoermer, K. A., & Morrison, T. E. (2011) · Virology · doi:10.1016/j.virol.2010.12.045 · Cited by 255
Complement and cytokine gene expression in cultured microglia derived from postmortem human brains
Walker, D. G., Kim, S. U., & McGeer, P. L. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400407 · Cited by 248
Rozemuller, J. M., Eikelenboom, P., Stam, F. C., Beyreuther, K., & Masters, C. L. (1989) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198911000-00009 · Cited by 243
Gasque, P., Fontaine, M., & Morgan, B. P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4726 · Cited by 241
BLOOD-BRAIN BARRIER DAMAGE IN ACUTE MULTIPLE SCLEROSIS PLAQUES: AN IMMUNOCYTOLOGICAL STUDY
GAY, D., & ESIRI, M. (1991) · Brain · doi:10.1093/brain/114.1.557 · Cited by 239
Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins
Yamada, T., McGeer, P. L., & McGeer, E. G. (1992) · Acta Neuropathologica · doi:10.1007/bf00427222 · Cited by 231
Localization and Cell Association of C1q in Alzheimer's Disease Brain
Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W., & Tenner, A. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0043 · Cited by 224
Self-citationComplement Activation in the Human Brain after Traumatic Head Injury
Bellander, B.-M., Singhrao, S. K., Ohlsson, M., Mattsson, P., & Svensson, M. (2001) · Journal of Neurotrauma · doi:10.1089/08977150152725605 · Cited by 221
Van BEEK, J., ELWARD, K., & GASQUE, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03138.x · Cited by 218
Distribution of clusterin in Alzheimer brain tissue
McGeer, P. L., Kawamata, T., & Walker, D. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90071-g · Cited by 212 · cited 1×
“Alternatively, the C5b-9 may be cleared since it associates either with membranes, clusterin or vitronectin (“S Protein”) (Itagaki et al., 1994;McGeer et al., 1992;Verbeek et al., 1998) rather than becoming covalently linked to the more long lived plaque as occurs with C4b/d and C3b/d. Strong…”
BackgroundChakrabarty, P., Ceballos-Diaz, C., Beccard, A., Janus, C., Dickson, D., Golde, T. E., & Das, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903382 · Cited by 206
The role of complement and activated microglia in the pathogenesis of Alzheimer's disease
Eikelenboom, P., & Veerhuis, R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00108-x · Cited by 206
Self-citationSynantocytes: the fifth element
Butt, A. M., Hamilton, N., Hubbard, P., Pugh, M., & Ibrahim, M. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00458.x · Cited by 201
Bohlson, S. S., Fraser, D. A., & Tenner, A. J. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.06.021 · Cited by 198
Self-citationPiddlesden, S. J., Storch, M. K., Hibbs, M., Freeman, A. M., Lassmann, H., & Morgan, B. P. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.11.5477 · Cited by 197
Fraser, D. A., Pisalyaput, K., & Tenner, A. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06494.x · Cited by 196
Self-citationBeyond lysis: how complement influences cell fate
COLE, D. S., & MORGAN, B. P. (2003) · Clinical Science · doi:10.1042/cs20020362 · Cited by 195
Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain
Shen, Y., Li, R., McGeer, E. G., & McGeer, P. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00850-0 · Cited by 195
Brink, B. P., Veerhuis, R., Breij, E. C. W., van der Valk, P., Dijkstra, C. D., & Bö, L. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.147 · Cited by 191
Self-citationThe cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
Bolliger, M. F., Martinelli, D. C., & Südhof, T. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019577108 · Cited by 189
Lévi-Strauss, M., & Mallat, M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.7.2361 · Cited by 188
Stoltzner, S. E., Grenfell, T. J., Mori, C., Wisniewski, K. E., Wisniewski, T. M., Selkoe, D. J., & Lemere, C. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64753-0 · Cited by 187
IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE SCLEROSIS
COMPSTON, D. A. S., MORGAN, B. P., CAMPBELL, A. K., WILKINS, P., COLE, G., THOMAS, N. D., & JASANI, B. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01231.x · Cited by 185
Johansson, L., Rytkönen, A., Bergman, P., Albiger, B., Källström, H., Hökfelt, T., Agerberth, B., Cattaneo, R., & Jonsson, A.-B. (2003) · Science · doi:10.1126/science.1086476 · Cited by 182
Morgan, D., Gordon, M. N., Tan, J., Wilcock, D., & Rojiani, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000178444.33972.e0 · Cited by 178
The complement cascade: Yin-Yang in neuroinflammation—neuro-protection and -degeneration
Alexander, J. J., Anderson, A. J., Barnum, S. R., Stevens, B., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05668.x · Cited by 177
Self-citationUdan, M. L. D., Ajit, D., Crouse, N. R., & Nichols, M. R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05001.x · Cited by 174
Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques
Ishii, T., & Haga, S. (1984) · Acta Neuropathologica · doi:10.1007/bf00687336 · Cited by 172
Shinjyo, N., Ståhlberg, A., Dragunow, M., Pekny, M., & Pekna, M. (2009) · Stem Cells · doi:10.1002/stem.225 · Cited by 171
The immunogenesis of the multiple sclerosis plaque
Lumsden, C. E. (1971) · Brain Research · doi:10.1016/0006-8993(71)90052-7 · Cited by 170
The role of the complement system in traumatic brain injury
Stahel, P. F., Morganti-Kossmann, M. C., & Kossmann, T. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00015-0 · Cited by 169
Relevance of Transgenic Mouse Models to Human Alzheimer Disease
Morrissette, D. A., Parachikova, A. I., Green, K. N., & LaFerla, F. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800030200 · Cited by 167
Complement gene expression in human brain: comparison between normal and Alzheimer disease cases
Walker, D. G., & McGeer, P. L. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90017-6 · Cited by 167
Immunoglobulins and complement in postmortem multiple sclerosis tissue
Barnett, M. H., Parratt, J. D. E., Cho, E., & Prineas, J. W. (2009) · Annals of Neurology · doi:10.1002/ana.21524 · Cited by 165
The Complement Factor C5a Contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis
Woodruff, T. M., Costantini, K. J., Crane, J. W., Atkin, J. D., Monk, P. N., Taylor, S. M., & Noakes, P. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8727 · Cited by 165
Nielsen, H. M., Mulder, S. D., Beliën, J. A. M., Musters, R. J. P., Eikelenboom, P., & Veerhuis, R. (2010) · Glia · doi:10.1002/glia.21004 · Cited by 165
Self-citationFraser, D. A., Laust, A. K., Nelson, E. L., & Tenner, A. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902232 · Cited by 163
Self-citationTacnet‐Delorme, P., Chevallier, S., & Arlaud, G. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6374 · Cited by 162
The Role of the Complement System and the Activation Fragment C5a in the Central Nervous System
Woodruff, T. M., Ager, R. R., Tenner, A. J., Noakes, P. G., & Taylor, S. M. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8085-y · Cited by 161
Self-citationThe complex of microglial cells and amyloid star in three-dimensional reconstruction
Wegiel, J., & Wisniewski, H. M. (1990) · Acta Neuropathologica · doi:10.1007/bf00334499 · Cited by 161
Active Disassembly of the First Complement Component, C1̄, by C1̄ Inactivator
Ziccardi, R. J., & Cooper, N. R. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.2.788 · Cited by 159
Wilcock, D. M., Alamed, J., Gottschall, P. E., Grimm, J., Rosenthal, A., Pons, J., Ronan, V., Symmonds, K., Gordon, M. N., & Morgan, D. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0695-06.2006 · Cited by 156
Veerhuis, R., Janssen, I., Groot, C. J. A. D., Muiswinkel, F. L. V., Hack, C. E., & Eikelenboom, P. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7199 · Cited by 154
Self-citationTherapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Woodruff, T. M., Crane, J. W., Proctor, L. M., Buller, K. M., Shek, A., Vos, K. J. D., Pollitt, S., Williams, H. M., Shiels, I. A., Monk, P. N., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5814com · Cited by 154
Neuronal Expression of a Functional Receptor for the C5a Complement Activation Fragment
O’Barr, S. A., Caguioa, J., Gruol, D. L., Perkins, G. A., Ember, J. A., Hugli, T. E., & Cooper, N. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4154 · Cited by 149
Velázquez, P., Cribbs, D. H., Poulos, T. L., & Tenner, A. J. (1997) · Nature Medicine · doi:10.1038/nm0197-77 · Cited by 149
Self-citationNeurons express proteins of the classical complement pathway in Alzheimer disease.
Terai, K., Walker, D., Mcgeer, E., & McGeer, P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00849-4 · Cited by 149
Expression of a complete and functional complement system by human neuronal cells in vitro
Thomas, A., Gasque, P., Vaudry, D., Gonzalez, B. J., & Fontaine, M. (2000) · International Immunology · doi:10.1093/intimm/12.7.1015 · Cited by 146
Bergamaschini, L., Rossi, E., Storini, C., Pizzimenti, S., Distaso, M., Perego, C., De Luigi, A., Vergani, C., & Grazia De Simoni, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0550-04.2004 · Cited by 146
Benoit (2011) · doi:10.1523/jneurosci.3932-10.2011 · Cited by 144
Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease
Zhou, J., Fonseca, M. I., Pisalyaput, K., & Tenner, A. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05558.x · Cited by 142
Self-citationGriffiths, M., Gasque, P., & Neal, J. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181996688 · Cited by 140
Osterwalder, T., Cinelli, P., Baici, A., Pennella, A., Krueger, S., Schrimpf, S., Meins, M., & Sonderegger, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2312 · Cited by 140
Sewell, D. L., Nacewicz, B. M., Liu, F., Macvilay, S., Erdei, A., Lambris, J. D., Sándor, M., & Fábry, Z. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.06.003 · Cited by 138
Reichwald, J., Danner, S., Wiederhold, K., & Staufenbiel, M. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-35 · Cited by 137
Singhrao, S. K., Neal, J., Rushmere, N. K., Morgan, B. P., & Gasque, P. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64604-4 · Cited by 134
Sairanen, T., Karjalainen‐Lindsberg, M., Paetau, A. E., Ijäs, P. H., & Lindsberg, P. J. (2005) · Brain · doi:10.1093/brain/awh645 · Cited by 126
Veerhuis, R., Van Breemen, M. J., Hoozemans, J. J., Morbin, M., Ouladhadj, J., Tagliavini, F., & Eikelenboom, P. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0624-7 · Cited by 123
Self-citationJohnson, R. T., Glass, J. D., McArthur, J. C., & Chesebro, B. W. (1996) · Annals of Neurology · doi:10.1002/ana.410390319 · Cited by 122
A secreted complement-control-related protein ensures acetylcholine receptor clustering
Gendrel, M., Rapti, G., Richmond, J. E., & Bessereau, J. (2009) · Nature · doi:10.1038/nature08430 · Cited by 121
Gasque, P., Ischenko, A. M., Legoedec, J., Mauger, C., Schouft, M., & Fontaine, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74572-4 · Cited by 117
Detection of complement alternative pathway mRNA and proteins in the Alzheimer’s disease brain
Strohmeyer, R., Shen, Y., & Rogers, J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00149-2 · Cited by 117
Recombinant C1 inhibitor in brain ischemic injury
Gesuete, R., Storini, C., Fantin, A., Stravalaci, M., Zanier, E. R., Orsini, F., Vietsch, H., Mannesse, M. L. M., Ziere, B., Gobbi, M., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21740 · Cited by 117
Complement activation in very early Alzheimer disease
Zanjani, H., Finch, C. E., Kemper, C., Atkinson, J., McKeel, D., Morris, J. C., & Price, J. L. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000165506.60370.94 · Cited by 115
Stoiber, H., Ebenbichler, C. F., Schneider, R., Janatova, J., & Dierich, M. P. (1995) · AIDS · doi:10.1097/00002030-199501000-00003 · Cited by 112
Itagaki, S., Akiyama, H., Saito, H., & McGeer, P. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)91640-3 · Cited by 112
Mukherjee, P., & Pasinetti, G. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00167.x · Cited by 111
Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration
Craft, J. M., Watterson, D. M., & Eldik, L. J. V. (2005) · Glia · doi:10.1002/glia.20306 · Cited by 111
Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death
van Beek, J., Nicole, O., Ali, C., Ischenko, A. M., MacKenzie, E. T., Buisson, A., & Fontaine, M. (2001) · Neuroreport · doi:10.1097/00001756-200102120-00022 · Cited by 110
Aggregation State‐Dependent Activation of the Classical Complement Pathway by the Amyloid β Peptide
Webster, S. D., Bradt, B. M., Rogers, J., & Cooper, N. R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010388.x · Cited by 109
Head, E., Azizeh, B. Y., Lott, I. T., Tenner, A. J., Cotman, C. W., & Cribbs, D. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0380 · Cited by 108
Self-citationLarsson, E., Lindvall, O., & Kokaia, Z. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02762-7 · Cited by 105
Wren, D. R., & Noble, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.9025 · Cited by 105
Pisalyaput, K., & Tenner, A. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05012.x · Cited by 103
Self-citationWooster, D. G., Maruvada, R., Blom, A. M., & Prasadarao, N. V. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02323.x · Cited by 100
Fonseca, M. I., Chu, S., Berci, A. M., Benoit, M. E., Peters, D. G., Kimura, Y., & Tenner, A. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-4 · Cited by 99
Self-citationIssa, P. C., Chong, V. N., & Scholl, H. P. N. (2010) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1568-6 · Cited by 98
Binding and uptake of Aβ1‐42 by primary human astrocytes in vitro
Nielsen, H. M., Veerhuis, R., Holmqvist, B., & Janciauskiene, S. (2009) · Glia · doi:10.1002/glia.20822 · Cited by 96
Self-citationProperdin: New roles in pattern recognition and target clearance
Kemper, C., & Hourcade, D. E. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.034 · Cited by 95
Expression of complement messenger RNAs and proteins by human oligodendroglial cells
Hosokawa, M., Klegeris, A., Maguire, J. A., & McGeer, P. L. (2003) · Glia · doi:10.1002/glia.10234 · Cited by 95
Eikelenboom, P., Veerhuis, R., van Exel, E. R., Hoozemans, J. J. M., Rozemüller, A. J. M., & van Gool, W. A. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256080 · Cited by 95
Self-citationCharacterization of C3a and C5a Receptors in Rat Cerebellar Granule Neurons during Maturation
Bénard, M., Gonzalez, B. J., Schouft, M., Falluel‐Morel, A., Vaudry, D., Chan, P., Vaudry, H., & Fontaine, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404124200 · Cited by 94
Recent advances in (patho)physiology of astroglia
Verkhratsky, A., & Parpura, V. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.108 · Cited by 94
Rozovsky, I., Morgan, T. E., Willoughby, D. A., Dugich‐Djordjevic, M. M., Pasinetti, G. M., Johnson, S. A., & Finch, C. E. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90473-1 · Cited by 93
C1, MBL–MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation
Beinrohr, L., Dobó, J., Závodszky, P., & Gál, P. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.009 · Cited by 92
Strohmeyer, R., Ramirez, M., Cole, G. J., Mueller, K., & Rogers, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00272-2 · Cited by 89
Erdei, A., Isaák, A., Török, K., Sándor, N., Kremlitzka, M., Prechl, J., & Bajtay, Z. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.181 · Cited by 88
Storini, C., Rossi, E., Marrella, V., Distaso, M., Veerhuis, R., Vergani, C., Bergamaschini, L. C., & Simoni, M. G. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.11.001 · Cited by 88
Self-citationDistribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer's disease
Verbeek, M. M., Otte‐Höller, I., Veerhuis, R., Ruiter, D. J., & de Waal, R. M. W. (1998) · Acta Neuropathologica · doi:10.1007/s004010050944 · Cited by 83
Self-citationEikelenboom, P., Veerhuis, R., van Exel, E., Hoozemans, J. J. M., Rozemüller, A. J. M., & van Gool, W. A. (2011) · Current Alzheimer Research · doi:10.2174/1567211213451672050 · Cited by 83
Self-citationTwo different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes
Sayah, S., Jauneau, A.-C., Patte‐Mensah, C., Tonon, M., Vaudry, H., & Fontaine, M. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00046-9 · Cited by 82
The possible role of complement activation in Alzheimer disease
McGeer, P. L., & McGeer, E. G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02422-x · Cited by 81
Histological and Direct Evidence for the Role of Complement in the Neuroinflammation of AD
Veerhuis, R. (2011) · Current Alzheimer Research · doi:10.2174/156720511794604589 · Cited by 80
Self-citationGasque, P., Thomas, A., Fontaine, M., & Morgan, B. P. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00015-x · Cited by 80
Plaque complement activation and cognitive loss in Alzheimer's disease
Loeffler, D. A., Camp, D. M., & Bennett, D. A. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-9 · Cited by 78
Early complement components in Alzheimer's disease brains
Veerhuis, R., Janssen, I., Hack, C. E., & Eikelenboom, P. (1995) · Acta Neuropathologica · doi:10.1007/s004019570001 · Cited by 77
Self-citationNeuronal localization of C1q in preclinical Alzheimer's disease
Fonseca, M. I., Kawas, C. H., Troncoso, J. C., & Tenner, A. J. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.004 · Cited by 77
Self-citationCbln and C1q family proteins – New transneuronal cytokines
Yuzaki, M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7550-3 · Cited by 77
The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer’s disease
Mukherjee, P., & Pasinetti, G. M. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00261-1 · Cited by 76
Koyanagi, S., Kuramoto, Y., Kimura, M., Oda, M., Kozako, T., Hayashida, S., Shimeno, H., & Soeda, S. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-04-0259 · Cited by 75
Veerhuis, R., van der Valk, P., Janssen, I., Zhan, S., Eikelenboom, P., & Nostrand, W. E. V. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00192116 · Cited by 74
Self-citationZhan, S., Veerhuis, R., Kamphorst, W., & Eikelenboom, P. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90018-7 · Cited by 72
Self-citationRole of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum
Bénard, M., Raoult, É., Vaudry, D., Leprince, J., Falluel‐Morel, A., Gonzalez, B. J., Galas, L., Vaudry, H., & Fontaine, M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.027 · Cited by 72
Lemere, C. A., Spooner, E. T., Leverone, J. F., Mori, C., & Clements, J. D. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00127-6 · Cited by 71
Hu, W., Ranaivo, H. R., Roy, S. M., Behanna, H. A., Wing, L. K., Munoz, L., Guo, L., Eldik, L. J. V., & Watterson, D. M. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.10.028 · Cited by 69
Complement and fungal pathogens: an update
Speth, C., Rambach, G., Würzner, R., & Lass‐Flörl, C. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01597.x · Cited by 69
Gasparini, L., Ongini, E., Wilcock, D. M., & Morgan, D. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.029 · Cited by 68
Neuroinvasion by pathogens: a key role of the complement system
Speth, C., Dierich, M. P., & Gasque, P. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(01)00104-3 · Cited by 67
Complement Activation in Chromosome 13 Dementias
Rostagno, A. A., Révész, T., Lashley, T., Tomidokoro, Y., Magnotti, L., Brændgaard, H., Plant, G. T., Bojsen‐Møller, M., Holton, J. L., Frangione, B., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206448200 · Cited by 67
The expression of complement regulatory proteins by adult human oligodendrocytes
Scolding, N. J., Morgan, B. P., & Compston, D. A. S. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00241-5 · Cited by 65
Activation of the Contact System in Cerebrospinal Fluid of Patients with Alzheimer Disease
Bergamaschini, L. C., Parnetti, L., Pareyson, D., Canziani, S., Cugno, M., & Agostoni, A. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199806000-00008 · Cited by 65
Complement C1-inhibitor expression in Alzheimer's disease
Veerhuis, R., Janssen, I., Hoozemans, J. J. M., Groot, C. J. A. D., Hack, C. E., & Eikelenboom, P. (1998) · Acta Neuropathologica · doi:10.1007/s004010050896 · Cited by 64
Self-citationInterleukin-1β and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes
Jauneau, A.-C., Ischenko, A. M., Chatagner, A., Bénard, M., Chan, P., Schouft, M., Patte‐Mensah, C., Vaudry, H., & Fontaine, M. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-8 · Cited by 63
Amyloid Associated Proteins in Alzheimers and Prion Disease
Veerhuis, R., Boshuizen, R. S., & Familian, A. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054038184 · Cited by 62
Self-citationRole of Complement in the Aetiology of Pickʼs Disease?
Singhrao, S. K., Biol, M., Neal, J., Gasque, P., Morgan, B. P., & Newman, G. R. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199605000-00010 · Cited by 61
Decreases in protease nexins in Alzheimer's disease brain
Choi, B.-T., Kim, R. C., Vaughan, P. J., Lau, A., Nostrand, W. E. V., Cotman, C. W., & Cunningham, D. D. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00060-r · Cited by 61
Yasojima, K., McGeer, E. G., & McGeer, P. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01514-0 · Cited by 58
Peng, Y., Jiang, L., Lee, D. Y. W., Schachter, S. C., Ma, Z., & Lemere, C. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20987 · Cited by 58
C4b-binding protein in Alzheimer's disease: Binding to Aβ1–42 and to dead cells
Trouw, L. A., Nielsen, H. M., Minthon, L., Londos, E., Landberg, G., Veerhuis, R., Janciauskiene, S. M., & Blom, A. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.04.025 · Cited by 54
Self-citationMinocycline does not affect amyloid β phagocytosis by human microglial cells
Familian, A., Eikelenboom, P., & Veerhuis, R. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.01.052 · Cited by 53
Self-citationInduction of complement proteins in a mouse model for cerebral microvascular Aβ deposition
Fan, R., DeFilippis, K., & Nostrand, W. E. V. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-22 · Cited by 52
Schwab, C., & McGeer, P. L. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7851 · Cited by 51
Activated microglial cells and complement factors are unrelated to cortical Lewy bodies
Rozemuller, A. J. M., Eikelenboom, P., Theeuwes, J. W., Jansen Steur, E. N. H., & de Vos, R. A. I. (2000) · Acta Neuropathologica · doi:10.1007/s004010000225 · Cited by 50
Synapse formation and maintenance by C1q family proteins: a new class of secreted synapse organizers
Yuzaki, M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07346.x · Cited by 45
Phagocytic Activity of Human Adult Astrocytes and Oligodendrocytes in Culture
Watabe, K., Osborne, D. L., & Kim, S. U. (1989) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198909000-00001 · Cited by 43
A Dual Receptor Crosstalk Model of G-Protein-Coupled Signal Transduction
Flaherty, P., Radhakrishnan, M. L., Dinh, T., Rebres, R. A., Roach, T. I. A., Jordan, M. I., & Arkin, A. P. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000185 · Cited by 43
van Kooten, C., Fiore, N., Trouw, L. A., Csomor, E., Xu, W., Castellano, G., Daha, M. R., & Gelderman, K. A. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.015 · Cited by 43
Maier, M., Seabrook, T. J., & Lemere, C. A. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.06.018 · Cited by 42
Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease
Ryman, D. C., Gao, Y., & Lamb, B. T. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.017 · Cited by 41
The complement factor C5a receptor is upregulated in NFL−/− mouse motor neurons
Humayun, S., Gohar, M., Volkening, K., Moisse, K., Leystra‐Lantz, C., Mepham, J. R., McLean, J. R., & Strong, M. J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.028 · Cited by 40
Vastag, M., Skopál, J., Krámer, J., Kolev, K., Vokó, Z., Csonka, É., Machovich, R., & Nagy, Z. (1998) · Immunobiology · doi:10.1016/s0171-2985(98)80059-4 · Cited by 38
Canova, C., Neal, J. W., & Gasque, P. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-22 · Cited by 36
Complement C1q Does Not Bind Monomeric β-Amyloid
Snyder, S. W., Wang, G. T., Barrett, L., Ladror, U. S., Casuto, D., Lee, C. M., Krafft, G. A., Holzman, R. B., & Holzman, T. F. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1121 · Cited by 34
Signaling through C5aR is not involved in basal neurogenesis
Bogestål, Y., Barnum, S., Smith, P. L. P., Mattisson, V., Pekny, M., & Pekna, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21401 · Cited by 32
Wang, W., & Passaniti, A. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990601)73:3<303::aid-jcb2>3.0.co;2-2 · Cited by 30
Verbeek, M. M., Otte‐Höller, I., Ruiter, D. J., & de Waal, R. M. W. (1999) · PubMed · Cited by 23
A molecular basis of activation of the alternative pathway of human complement.
Austen, K. F., & Fearon, D. T. (1979) · PubMed · Cited by 22
Kobayashi, K., Muramori, F., Aoki, T., Hayashi, M., Miyazu, K., Fukutani, Y., Mukai, M., & Koshino, F. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017015 · Cited by 16
CD59 Efficiently Protects Human NT2‐N Neurons Against Complement‐mediated Damage
Pedersen, E. D., Aass, H. C. D., Rootwelt, T., Fung, M., Lambris, J. D., & Mollnes, T. E. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.01959.x · Cited by 15
Cadman, E. D., & Puttfarcken, P. S. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6540 · Cited by 12
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
The Complement System: An Unexpected Role in Synaptic Pruning During Development and Disease
Stephan, A. H., Barres, B. A., & Stevens, B. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113810 · Cited by 1,113
The blood–brain barrier in health and disease
Daneman, R. (2012) · Annals of Neurology · doi:10.1002/ana.23648 · Cited by 754
Phagocytosis of Microglia in the Central Nervous System Diseases
Fu, R., Shen, Q., Xu, P., Luo, J. J., & Tang, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8620-6 · Cited by 652
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593
Metadata
- Authors
- Veerhuis, R., Nielsen, H. M., & Tenner, A. J.
- Venue
- Molecular Immunology
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 48
- Issue
- 14
- Pages
- 1592-1603
- ISSN
- 0161-5890 (ISSN-L)
- OpenAlex
- W2164179897
- Cited by
- 419
- References
- 198
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.